Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer.
Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer.
复制标题
空间结构和肿瘤浸润淋巴细胞的排列,以预测早期非小细胞肺癌中复发的可能性。
DOI:
10.1158/1078-0432.ccr-18-2013
复制
发表时间:
2019-03-01
期刊:
影响因子:
--
通讯作者:
Madabhushi A
中科院分区:
文献类型:
--
作者:
Corredor G;Wang X;Zhou Y;Lu C;Fu P;Syrigos K;Rimm DL;Yang M;Romero E;Schalper KA;Velcheti V;Madabhushi A
Presence of a high degree of tumor-infiltrating lymphocytes (TILs) has proven to be associated with outcome in patients with non-small cell lung cancer (NSCLC). However, recent evidence indicate that tissue architecture is also prognostic of disease specific survival and recurrence. We show a set of descriptors (SpaTIL) that capture density and spatial co-localization of TILs and tumor cells across digital images can predict likelihood of recurrence in early-stage NSCLC. The association between recurrence in early-stage NSCLC and SpaTIL features was explored on 301 patients across four different cohorts. Cohort D1 (n=70) was used to identify the most prognostic SpaTIL features and to train a classifier to predict the likelihood of recurrence. The classifier performance was evaluated in cohorts D2 (n=119), D3 (n=112), and D4 (n=112). Two pathologists graded each sample of D1 and D2; intra-observer agreement and association between manual grading and likelihood of recurrence were analyzed. SpaTIL was associated with likelihood of recurrence in all test sets (log rank p<0.02). A multivariate Cox Proportional Hazards analysis revealed a HR of 3.08 (95% confidence interval, 2.1–4.5, p=7.3×10−5). In contrast, agreement among expert pathologists using tumor grade was moderate (Kappa=0.5), and the manual TIL grading was only prognostic for one reader in D2 (p=8.0×10−3). A set of features related to density and spatial architecture of TILs was found to be associated with a likelihood of recurrence of early-stage NSCLC. This information could potentially be used for helping in treatment planning and management of early-stage NSCLC.